Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Silvia Veneroni"'
Autor:
Roberto Agresti, Massimiliano Gennaro, Maria Grazia Daidone, Giovanni Apolone, Luigi Mariani, Serena Di Cosimo, Ilaria Ardoino, Elia Biganzoli, Silvia Veneroni, Romano Demicheli, Filippo de Braud
Publikováno v:
Breast (Edinburgh, Scotland). 40
Background Breast cancer (BC) patients with ipsilateral breast tumor recurrence (IBTR) are at high risk of developing distant metastases (DM). We aimed to evaluate the risk pattern of developing DM, with respect to the occurrence of IBTR, in a large
Autor:
Zhimin Shao, Loris De Cecco, Maria Luisa Carcangiu, Jingyan Xue, Sylvie Ménard, Rosaria Orlandi, Rui Bi, Barbara Valeri, Silvia Veneroni, Maurizio Callari, Xiaoyan Huang, Elda Tagliabue, Marco Sandri, Matteo Dugo, Maria Grazia Daidone, Jiong Wu
Publikováno v:
Cancer Medicine
The recent dramatic increase in breast cancer incidence across China with progressive urbanization and economic development has signaled the urgent need for molecular and clinical detailing of breast cancer in the Chinese population. Our analyses of
Publikováno v:
British Journal of Cancer
To obtain a more integrated understanding of the different breast cancer phenotypes and to investigate whether bio-molecular profiles can distinguish between specific histotypes, we explored the interrelations among several biologic variables indicat
Autor:
Umberto Veronesi, Patrizia Boracchi, Maria Grazia Daidone, Rosella Silvestrini, Maura Mezzetti, Franco Rilke, E. Benini, Silvia Veneroni, Giovanni Di Fronzo
Publikováno v:
Scopus-Elsevier
BACKGROUND The bcl-2 gene (also known as BCL2) encodes for a mitochondrial protein thought to prevent apoptosis of normal cells. The protein has been detected by immunohistochemical procedures in hormonally regulated epithelia. PURPOSE We analyzed th
Autor:
E. Benini, Silvia Veneroni, Vera Cappelletti, G. Di Fronzo, Maria Grazia Daidone, Umberto Veronesi, Patrizia Boracchi, Rosella Silvestrini
Publikováno v:
Scopus-Elsevier
BACKGROUND At present, most decisions concerning the use of adjuvant therapy in lymph node-negative breast cancer patients are made on the basis of traditional factors such as tumor size, nodal status, and histopathologic features. However, prognosti
Autor:
Valeria Musella, Loris De Cecco, Silvia Veneroni, Maria Grazia Daidone, Manuela Gariboldi, Maurizio Callari, Vera Cappelletti, Marco A. Pierotti, Patrizia Miodini
Publikováno v:
Breast cancer research and treatment. 127(3)
Male breast cancer (MBC) is a poorly characterized disease because of its rarity. Clinical management is based on results obtained from randomized trials conducted in women notwithstanding data in the literature suggesting relevant gender-associated
Autor:
Mark E. Robson, Silvia Veneroni, Maria Grazia Daidone, Noah D. Kauff, Lauren Scheuer, Kenneth Offit, Paolo Radice, Vera Cappelletti, Mamoun Younes, Marco A. Pierotti
Publikováno v:
Journal of Clinical Oncology. 20:3752-3753